N
,U636/NU 636 Advanced Pharmacology
Quiz 1 Bundle | Herzing | 26/27
Actual(PDF)
1. A client with a history of heart failure is prescribed a medication that undergoes extensive first-pass
metabolism. Which route of administration would bypass this effect and provide the highest
bioavailability?
A) Oral tablet
B) Sublingual tablet
C) Enteric-coated capsule
D) Rectal suppository
Correct Answer: Sublingual tablet
Rationale: First-pass metabolism refers to the biotransformation of a drug in the liver and gut wall
before it reaches systemic circulation. Drugs administered orally are absorbed into the portal
circulation and pass through the liver, where a significant fraction may be metabolized. Sublingual
administration allows the drug to be absorbed directly into the systemic circulation via the venous
drainage under the tongue, bypassing the hepatic portal system and avoiding first-pass metabolism.
This route provides high bioavailability and a rapid onset of action. Oral tablets and enteric-coated
capsules are subject to first-pass metabolism. Rectal suppositories have partial avoidance of first-pass
metabolism, but absorption is often erratic and incomplete.
2. A patient with a history of renal impairment is prescribed an aminoglycoside antibiotic. Which
pharmacokinetic parameter requires the most careful monitoring to prevent toxicity?
A) Volume of distribution
B) Protein binding
C) Renal clearance
D) Hepatic metabolism
,Correct Answer: Renal clearance
Rationale: Aminoglycosides are primarily eliminated unchanged by the kidneys through glomerular
filtration. In patients with renal impairment, the clearance of aminoglycosides is significantly reduced,
leading to accumulation and an increased risk of nephrotoxicity and ototoxicity. While volume of
distribution and protein binding can be altered in renal impairment, renal clearance is the most critical
parameter to monitor for dose adjustment. Aminoglycosides are not significantly metabolized by the
liver, so hepatic metabolism is not a primary concern.
3. A patient is started on a medication that is a potent inhibitor of cytochrome P450 3A4. Which
potential drug interaction should the nurse anticipate?
A) Decreased plasma concentration of drugs metabolized by CYP3A4
B) Increased plasma concentration of drugs metabolized by CYP3A4
C) Decreased plasma concentration of drugs that are substrates of CYP3A4
D) No significant interaction with other drugs
Correct Answer: Increased plasma concentration of drugs metabolized by CYP3A4
Rationale: Cytochrome P450 3A4 is a major enzyme involved in the metabolism of many drugs.
Inhibiting this enzyme reduces the metabolic clearance of drugs that are substrates of CYP3A4, leading
to increased plasma concentrations and an elevated risk of adverse effects. A classic example is the
interaction between ketoconazole (a potent CYP3A4 inhibitor) and certain statins, which can increase
statin levels and the risk of rhabdomyolysis. Enzyme inducers, such as rifampin, would decrease
plasma concentrations of CYP3A4 substrates.
4. A patient with a history of asthma is prescribed a short-acting beta-agonist for acute symptom
relief. Which mechanism of action explains the bronchodilatory effect of this medication?
A) Inhibition of leukotriene synthesis
B) Blockade of muscarinic receptors
C) Stimulation of beta-2 adrenergic receptors
, D) Inhibition of phosphodiesterase
Correct Answer: Stimulation of beta-2 adrenergic receptors
Rationale: Short-acting beta-agonists, such as albuterol, work by selectively stimulating beta-2
adrenergic receptors on bronchial smooth muscle. This stimulation activates intracellular signaling
pathways that lead to smooth muscle relaxation and rapid bronchodilation, providing relief from
acute bronchospasm. Leukotriene synthesis inhibitors and receptor antagonists are used for chronic
asthma control. Muscarinic receptor antagonists, such as ipratropium, also cause bronchodilation but
through a different mechanism. Phosphodiesterase inhibitors, such as theophylline, have a narrower
therapeutic index and are not first-line for acute relief.
5. A patient is prescribed warfarin for atrial fibrillation. Which instruction should the nurse include in
the teaching plan regarding dietary vitamin K intake?
A) "Avoid all foods rich in vitamin K."
B) "Maintain a consistent intake of vitamin K-rich foods."
C) "Increase your intake of vitamin K-rich foods to prevent bleeding."
D) "Vitamin K intake does not affect warfarin therapy."
Correct Answer: "Maintain a consistent intake of vitamin K-rich foods."
Rationale: Warfarin is a vitamin K antagonist that inhibits the synthesis of clotting factors. The
international normalized ratio (INR) is used to monitor its therapeutic effect. Fluctuations in vitamin K
intake can alter the INR, leading to either increased bleeding risk (if intake is decreased) or decreased
anticoagulant effect (if intake is increased). Clients should be taught to maintain a consistent daily
intake of vitamin K-rich foods, such as leafy green vegetables, rather than avoiding them entirely.
Consistency is key to stable anticoagulation.
6. A patient with type 2 diabetes is prescribed metformin. Which statement best describes the
primary mechanism of action of this medication?
A) Increases insulin secretion from pancreatic beta cells
,U636/NU 636 Advanced Pharmacology
Quiz 1 Bundle | Herzing | 26/27
Actual(PDF)
1. A client with a history of heart failure is prescribed a medication that undergoes extensive first-pass
metabolism. Which route of administration would bypass this effect and provide the highest
bioavailability?
A) Oral tablet
B) Sublingual tablet
C) Enteric-coated capsule
D) Rectal suppository
Correct Answer: Sublingual tablet
Rationale: First-pass metabolism refers to the biotransformation of a drug in the liver and gut wall
before it reaches systemic circulation. Drugs administered orally are absorbed into the portal
circulation and pass through the liver, where a significant fraction may be metabolized. Sublingual
administration allows the drug to be absorbed directly into the systemic circulation via the venous
drainage under the tongue, bypassing the hepatic portal system and avoiding first-pass metabolism.
This route provides high bioavailability and a rapid onset of action. Oral tablets and enteric-coated
capsules are subject to first-pass metabolism. Rectal suppositories have partial avoidance of first-pass
metabolism, but absorption is often erratic and incomplete.
2. A patient with a history of renal impairment is prescribed an aminoglycoside antibiotic. Which
pharmacokinetic parameter requires the most careful monitoring to prevent toxicity?
A) Volume of distribution
B) Protein binding
C) Renal clearance
D) Hepatic metabolism
,Correct Answer: Renal clearance
Rationale: Aminoglycosides are primarily eliminated unchanged by the kidneys through glomerular
filtration. In patients with renal impairment, the clearance of aminoglycosides is significantly reduced,
leading to accumulation and an increased risk of nephrotoxicity and ototoxicity. While volume of
distribution and protein binding can be altered in renal impairment, renal clearance is the most critical
parameter to monitor for dose adjustment. Aminoglycosides are not significantly metabolized by the
liver, so hepatic metabolism is not a primary concern.
3. A patient is started on a medication that is a potent inhibitor of cytochrome P450 3A4. Which
potential drug interaction should the nurse anticipate?
A) Decreased plasma concentration of drugs metabolized by CYP3A4
B) Increased plasma concentration of drugs metabolized by CYP3A4
C) Decreased plasma concentration of drugs that are substrates of CYP3A4
D) No significant interaction with other drugs
Correct Answer: Increased plasma concentration of drugs metabolized by CYP3A4
Rationale: Cytochrome P450 3A4 is a major enzyme involved in the metabolism of many drugs.
Inhibiting this enzyme reduces the metabolic clearance of drugs that are substrates of CYP3A4, leading
to increased plasma concentrations and an elevated risk of adverse effects. A classic example is the
interaction between ketoconazole (a potent CYP3A4 inhibitor) and certain statins, which can increase
statin levels and the risk of rhabdomyolysis. Enzyme inducers, such as rifampin, would decrease
plasma concentrations of CYP3A4 substrates.
4. A patient with a history of asthma is prescribed a short-acting beta-agonist for acute symptom
relief. Which mechanism of action explains the bronchodilatory effect of this medication?
A) Inhibition of leukotriene synthesis
B) Blockade of muscarinic receptors
C) Stimulation of beta-2 adrenergic receptors
, D) Inhibition of phosphodiesterase
Correct Answer: Stimulation of beta-2 adrenergic receptors
Rationale: Short-acting beta-agonists, such as albuterol, work by selectively stimulating beta-2
adrenergic receptors on bronchial smooth muscle. This stimulation activates intracellular signaling
pathways that lead to smooth muscle relaxation and rapid bronchodilation, providing relief from
acute bronchospasm. Leukotriene synthesis inhibitors and receptor antagonists are used for chronic
asthma control. Muscarinic receptor antagonists, such as ipratropium, also cause bronchodilation but
through a different mechanism. Phosphodiesterase inhibitors, such as theophylline, have a narrower
therapeutic index and are not first-line for acute relief.
5. A patient is prescribed warfarin for atrial fibrillation. Which instruction should the nurse include in
the teaching plan regarding dietary vitamin K intake?
A) "Avoid all foods rich in vitamin K."
B) "Maintain a consistent intake of vitamin K-rich foods."
C) "Increase your intake of vitamin K-rich foods to prevent bleeding."
D) "Vitamin K intake does not affect warfarin therapy."
Correct Answer: "Maintain a consistent intake of vitamin K-rich foods."
Rationale: Warfarin is a vitamin K antagonist that inhibits the synthesis of clotting factors. The
international normalized ratio (INR) is used to monitor its therapeutic effect. Fluctuations in vitamin K
intake can alter the INR, leading to either increased bleeding risk (if intake is decreased) or decreased
anticoagulant effect (if intake is increased). Clients should be taught to maintain a consistent daily
intake of vitamin K-rich foods, such as leafy green vegetables, rather than avoiding them entirely.
Consistency is key to stable anticoagulation.
6. A patient with type 2 diabetes is prescribed metformin. Which statement best describes the
primary mechanism of action of this medication?
A) Increases insulin secretion from pancreatic beta cells
